2023³â Á¦7Â÷ ³»°úºÐ°úÀü¹®ÀÇ ¿¬¼ö±³À° : 2024-06-01
±³À°ÀÏÀÚ : 2024-06-01
±³À°Àå¼Ò : ¼¿ï ½ºÀ§½º±×·£µåÈ£ÅÚ
±³À°ÁÖÁ¦ : 2023³â Á¦7Â÷ ³»°úºÐ°úÀü¹®ÀÇ ¿¬¼ö±³À°
ÁÖÃÖ±â°ü : ´ëÇѳ»°úÇÐȸ
¿¬¶ôó : 02-793-4364
À̸ÞÀÏ : kaim4364@kaim.or.kr
±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀÎ : 1500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 27 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 80,000¿ø
ºñ°í "³»°úȸ¿ø: »çÀüµî·Ï - 50,000¿ø / ´çÀϵî·Ï 60,000¿ø
ºñȸ¿ø(Ÿ°ú): »çÀüµî·Ï - 70,000¿ø / ´çÀϵî·Ï 80,000¿ø"
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06¿ù 01ÀÏ 1°ÀÇ½Ç 13:30~13:55 Diagnosis and Management of Functional Dyspepsia ¿ÀÁ¤È¯(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 1°ÀÇ½Ç 13:55~14:15 Diagnosis and Management of Eosinophilic Esophagitis Á¤±â¿í(¿ï»êÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 1°ÀÇ½Ç 14:15~14:40 Diagnosis and Treatment of Functional Constipation À±Áø¿µ(°æÈñÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 1°ÀÇ½Ç 14:40~15:00 Recent Update on the Management of Inflammatory Bowel Disease ¼ÛÀº¹Ì(ÀÌÈÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 1°ÀÇ½Ç 15:30~15:55 Recent Update on the Management of Steatotic Liver Disease ÀÌÀç½Â(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 1°ÀÇ½Ç 15:55~16:15 Simplified Treatment for Hepatitis C Virus ÀÌÇѾÆ(ÀÌÈÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 1°ÀÇ½Ç 16:15~16:40 Diagnosis and Management of Gallstone Diseases ·ù±âÇö(°Ç¾çÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 1°ÀÇ½Ç 16:40~17:00 Recent Update on the Management of Biliary Tract Cancer ÃÖÁøÈ£(¼¿ïÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 2°ÀÇ½Ç 08:30~09:00 Current Guidelines for Heart Failure À±Á¾Âù(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 2°ÀÇ½Ç 09:00~09:30 Current Guidelines for Hypertension ÀÌÂùÁÖ (¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 2°ÀÇ½Ç 09:30~10:00 Current Guidelines for Acute Coronary Syndrome À±ÇõÁØ(°è¸íÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 2°ÀÇ½Ç 10:30~11:00 Update on Atrial Fibrillation °íÁ¡¼®(¿ø±¤ÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 2°ÀÇ½Ç 11:00~11:30 Update on Valvular Heart Disease ¼ÕÁ¤¿ì(¿¬¼¼¿øÁÖÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 2°ÀÇ½Ç 11:30~12:00 Update on Bradyarrhythmia ¹ÚÁ¾¼º(µ¿¾ÆÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 4°ÀÇ½Ç 13:30~14:00 FeNO/IOS ÀÌ Çö( ÇѾçÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 4°ÀÇ½Ç 14:00~14:30 Transbronchial Biopsy for Peripheral Lung Lesions ¾öÁß¼·(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 4°ÀÇ½Ç 14:30~15:00 Thoracic Ultrasound ¾ÈÅÂÁØ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 4°ÀÇ½Ç 15:30~16:00 Update on Inhaler Treatment for Chronic Airway Disease ½Å¼±Çý (°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 4°ÀÇ½Ç 16:00~16:30 Update of PPF: Diagnosis and Treatment ÀÌÀçÇÏ(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 4°ÀÇ½Ç 16:30~17:00 Immunotherapy for Non-Small Cell Lung Cancer ±è¹ÌÇö(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 5°ÀÇ½Ç 08:30~09:00 Diagnosis and Management of Diabetes; Lesson from Recent Guidelines °½Å¾Ö(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 5°ÀÇ½Ç 09:00~09:30 Novel Role of Mineralocorticoid Receptor Inhibition in the Treatment of Diabetic Kidney Disease ±è³Èñ(°í·ÁÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 5°ÀÇ½Ç 09:30~10:00 CGM and Automated Insulin Delivery Áø»ó¸¸(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 5°ÀÇ½Ç 10:30~11:00 Discrimination of Secondary Osteoporosis À̽ÂÈÆ(¿ï»êÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 5°ÀÇ½Ç 11:00~11:30 Treatment Guidelines for Hypoparathyroidism ¾È¼ºÈñ(ÀÎÇÏÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 5°ÀÇ½Ç 11:30~12:00 Recent Update for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis ¹Ú¼Ò¿µ(°æÈñÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 3°ÀÇ½Ç 13:30~14:00 Basic Overview of Electrolytes and Acid-Base Balance in Renal Physiology ÀåÇý·Ã(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 3°ÀÇ½Ç 14:00~14:30 Sodium and Water Balance Disorder ¹®ÁÖ¿µ(°æÈñÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 3°ÀÇ½Ç 14:30~15:00 Potassium Disorder in Hospitalized and Critically ill Patients °íÀº½Ç(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 3°ÀÇ½Ç 15:30~16:00 High Anion-Gap Metabolic Acidosis ±Ç¼ø±æ(ÃæºÏÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 3°ÀÇ½Ç 16:00~16:30 Acid-Base Disorders in Hospitalized and Critically ill Patients °¼®ÈÖ(¿µ³²ÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 3°ÀÇ½Ç 16:30~17:00 Metabolic Acidosis in Patients with CKD ±èÀÏ¿µ(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 1°ÀÇ½Ç 08:30~09:00 Recent Advances in AML ¹Ú¿ë(°í·ÁÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 1°ÀÇ½Ç 09:00~09:30 Recent Advances in MPN È«ÁؽÄ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 1°ÀÇ½Ç 09:30~10:00 Recent Advances in MM ±è°æÇÏ(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 1°ÀÇ½Ç 10:30~11:00 Biomarker in solid tumor using liquid biopsy ±è¸í½Å(°¡Å縯ÀÇ´ë Áø´Ü°Ë»çÀÇÇаú)
±³À°½Ã°£ 06¿ù 01ÀÏ 1°ÀÇ½Ç 11:00~11:30 Application of ct DAN in clinical practice Â÷¿ëÁØ(±¹¸³¾Ï¼¾ÅÍ)
±³À°½Ã°£ 06¿ù 01ÀÏ 1°ÀÇ½Ç 11:30~12:00 Different signal of PD-L1 in solid tumor as biomarker Á¤¹Î±Ô(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 2°ÀÇ½Ç 13:30~14:00 Current Update on Diagnostic approach of Infectious Diseases ¹Ú¼º±Õ(°è¸íÀÇ´ë Áø´Ü°Ë»çÀÇÇаú)
±³À°½Ã°£ 06¿ù 01ÀÏ 2°ÀÇ½Ç 14:00~14:30 How to use Recently Approved Broad Spectrum Beta-lactams? À±¿µ°æ(°í·ÁÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 2°ÀÇ½Ç 14:30~15:00 Long-awaited novel antibiotics still not introduced in Korea ÀÌÈ¿Áø(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 2°ÀÇ½Ç 15:30~16:00 Adult Immunization Policy in Korea ÇãÁß¿¬(¾ÆÁÖÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 2°ÀÇ½Ç 16:00~16:30 Guidelines on the Diagnosis and Treatment of Diabetes-related Foot Infections ÃÖÀç±â(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 2°ÀÇ½Ç 16:30~17:00 Management of Endocarditis: 2023 ESC Guidelines for the Management of Endocarditis Á¶µ¿È£(¸íÁöº´¿ø)
±³À°½Ã°£ 06¿ù 01ÀÏ 3°ÀÇ½Ç 08:30~09:15 Implementing Anti-Inflammatory Reliever Strategies in Mild to Moderate Asthma ÀÌÁöÈ£(¿¬¼¼¿øÁÖÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 3°ÀÇ½Ç 09:15~10:00 Management and New Targeted Therapies in Chronic Cough ±è¹ÎÇý(ÀÌÈÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 3°ÀÇ½Ç 10:30~11:00 Drug Allergy Delabeling in Clinical Practice ±è¼º·Ä(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 3°ÀÇ½Ç 11:00~11:30 Advances in Mechanisms and Management of Delayed Drug Hypersensitivity Reaction ½É´Ù¿î(Àü³²ÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 3°ÀÇ½Ç 11:30~12:00 Current and Future Management of Chronic Spontaneous Urticaria and Chronic Inducible Urticaria ÀÌÁöÇâ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 4°ÀÇ½Ç 08:30~09:00 Update of Osteoarthritis & Osteoporosis ±èÇö¾Æ(¾ÆÁÖÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 4°ÀÇ½Ç 09:00~09:30 Novel Treatments in Inflammatory Myopathy ¹®¼öÁø(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 4°ÀÇ½Ç 09:30~10:00 Update of Rheumatoid Arthritis õÀ±È«(°æ»óÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 4°ÀÇ½Ç 10:30~11:00 Corticosteroid-Free Adalimumab-Cyclophosphamide Combination Therapy for Acute Phase Neuro-Behçet¡¯s Disease Ç¥Á¤À±(¼¿ïÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 4°ÀÇ½Ç 11:00~11:30 Immunoglobulin G4-Related Hypertrophic Pachymeningitis with an Isolated Scalp Mass Mimicking a Brain Tumor ÃÖÈ¿Áø(°¡ÃµÀÇ´ë)
±³À°½Ã°£ 06¿ù 01ÀÏ 4°ÀÇ½Ç 11:30~12:00 Fatal Hemorrhagic Polymyositis Á¤Á¾Çõ(¿ø±¤ÀÇ´ë)